Bank KB Bukopin Tbk vs Merck Tbk. — how do they compare? Bank KB Bukopin Tbk trades at Rp51 (market cap 9.48T, 58.77M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Bank KB Bukopin Tbk is far larger — about 5.6× Merck Tbk.'s market cap, and Bank KB Bukopin Tbk is more actively traded (58.77M versus 22.8K). Which is the better fit depends on your goals.
| BBKP | MERK | |
|---|---|---|
Market Cap | 9.48T | 1.68T |
Volume | 58.77M | 22.8K |
Lot | 587.74K | 228 |
Turnover | 2.99B | 82.9M |
Average Price | 50.79 | 3,636.14 |
Value | 2.99B | 82.9M |
Indicative Equilibrium Price | 51 | 3,520 |
Indicative Equilibrium Volume | 11.64K | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Bukopin Tbk (the Bank) was established under its original name of Bank Umum Koperasi Indonesia (abbreviated to Bukopin) on Jul 10th, 1970 then changed to PT Bank Bukopin based on Notaries Deed dated Feb 25, 1993 and the deed of establishment was approved by the the Ministry of Justice dated June 29, 1993. The Bank started commercial operations as a limited liability company on July 1, 1993.
Read more on BBKP →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →